Bristol-Myers Squibb Co.’s blockbuster cancer drug Opdivo prolonged survival in cases of recurrent head and neck cancer, a first for patients with the harshest form of the disease who often face a bleak prognosis.
A Medicare proposal to test new ways of paying for chemotherapy and other drugs given in a doctor's office has sparked a furious battle, and cancer doctors are demanding that the Obama administration scrap the experiment.
Dr. Joseph Tector, who built IU Health’s transplant program into one of the nation’s largest before announcing his departure Friday, is seeking back wages and penalties worth $4.7 million from the hospital system.
The three drugmakers that dominate the world diabetes market—Eli Lilly and Co., Novo Nordisk A/S and Sanofi—are introducing improved forms of insulin, with a price tag to match.
The biggest U.S.-based drugmaker, Pfizer Inc., will stay put thanks to aggressive new Treasury Department rules that succeeded in blocking Pfizer from acquiring rival Allergan and moving to Ireland—on paper—to reduce its tax bill.
Across Indiana, 64 hospitals are facing total federal penalties this year estimated at $9.3 million, according to the Indiana Hospital Association. Nationally, hospitals will pay an estimated $420 million.
Seth Warren, who served a short tenure as CEO of Laconia, New Hampshire-based LRGHealthcare, will replace Pat Fox as head of Noblesville-based Riverview on April 25.
The $10 million facility at 5315 Lafayette Road in Pike Township will be named the OrthoIndy Foundation YMCA and offer medical care and other services tailored to veterans and their families.
For Eli Lilly and Co., the approval rewards a decade-long effort to re-enter the biotech and autoimmune spaces that it helped pioneer in the 1980s but then abandoned in the 1990s.
The Indianapolis Airport Authority board said it would “leave our options open and continue to search for the optimal project.”
Airport authority board Chairman Kelly Flynn sent an email Tuesday evening to other board members, telling them “we need to take a step back” on Athlete’s Business Network’s plan.
Shares in Eli Lilly and Co. fell Tuesday on concerns surrounding the potential approval of a drug designed to treat dementia caused by Alzheimer's disease.
The company announced Monday that a missing laptop contains the names, addresses, Social Security numbers and other confidential information of more than 200,000 patients.
Under the deal, Franciscan was financially accountable for what it would spend on care for about 60,000 patients who had Anthem benefits provided by its employers or purchased individually. Would it work?
The new funding builds on the $18 million NICO Corp. has raised from investors since its founding in 2008. The money will help the firm conduct clinical trials, commercialize new products and expand its staff beyond North America.
The Indiana Biosciences Research Institute, set up just three years ago, announced Wednesday morning that it has been awarded grants of $80 million from the Lilly Endowment and $20 million from the Eli Lilly and Co. Foundation.
The top executive at an Indianapolis start-up that wants to build a $500 million medical complex at the Indianapolis International Airport launched a 200-location Dunkin' Donuts business that went bankrupt in 2009 and he filed for personal bankruptcy in 2013.
The trauma center at St. Vincent Indianapolis has become the third such facility in the state to be recognized as a Level I Trauma Center, meaning it is equipped and staffed to handle the most serious injuries.
Teva’s acquisition will make it the world’s largest maker of generic medicines, giving it greater negotiating power with governments and private-health insurers.
The Bloomington company’s latest recall comes as the company is dealing with a deluge of product lawsuits.
